KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $14.7 million.

  • Hologic's Capital Expenditures fell 1250.0% to $14.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.7 million, marking a year-over-year decrease of 1473.68%. This contributed to the annual value of $58.8 million for FY2025, which is 1878.45% down from last year.
  • As of Q4 2025, Hologic's Capital Expenditures stood at $14.7 million, which was down 1250.0% from $13.7 million recorded in Q3 2025.
  • Over the past 5 years, Hologic's Capital Expenditures peaked at $36.3 million during Q3 2023, and registered a low of $12.8 million during Q1 2024.
  • In the last 5 years, Hologic's Capital Expenditures had a median value of $17.8 million in 2023 and averaged $19.7 million.
  • As far as peak fluctuations go, Hologic's Capital Expenditures surged by 8333.33% in 2023, and later plummeted by 5482.09% in 2024.
  • Over the past 5 years, Hologic's Capital Expenditures (Quarter) stood at $20.5 million in 2021, then decreased by 22.93% to $15.8 million in 2022, then soared by 43.67% to $22.7 million in 2023, then dropped by 25.99% to $16.8 million in 2024, then dropped by 12.5% to $14.7 million in 2025.
  • Its Capital Expenditures was $14.7 million in Q4 2025, compared to $13.7 million in Q3 2025 and $12.8 million in Q2 2025.